A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome*

MLA

Daniel P. Schuster, et al. “A Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of L-2-Oxothiazolidine-4-Carboxylic Acid in the Treatment of Patients with Acute Respiratory Distress Syndrome*.” Critical Care Medicine, vol. 36, Mar. 2008, pp. 782–88. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....79343e026e79c17bd0f334c91a0d50cf&authtype=sso&custid=ns315887.

APA

Daniel P. Schuster, James A. Russell, Peter J. Papadakos, Richard G. Wunderink, Peter E. Morris, Jean Louis Vincent, Jonathon D. Truwit, & Gordon R. Bernard. (2008). A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome*. Critical Care Medicine, 36, 782–788.

Chicago

Daniel P. Schuster, James A. Russell, Peter J. Papadakos, Richard G. Wunderink, Peter E. Morris, Jean Louis Vincent, Jonathon D. Truwit, and Gordon R. Bernard. 2008. “A Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of L-2-Oxothiazolidine-4-Carboxylic Acid in the Treatment of Patients with Acute Respiratory Distress Syndrome*.” Critical Care Medicine 36 (March): 782–88. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....79343e026e79c17bd0f334c91a0d50cf&authtype=sso&custid=ns315887.